ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994